LP
SBBP

LMR Partners’s Strongbridge Biopharma plc. SBBP Stock Holding History

LMR Partners’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-20,742
Closed -$62K – 1306
2021
Q2 		$62K Buy
+20,742
New +$54.8K ﹤0.01% 957
2018
Q3 		– Sell
-92,540
Closed -$555K – 554
2018
Q2 		$555K Buy
+92,540
New +$677K 0.03% 243

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

LMR Partners's SBBP Position: Q3 2021 in Review

LMR Partners sold out of Strongbridge Biopharma plc. (SBBP) in Q3 2021, closing a stake of 20,742 shares — an estimated $62K sold.

LMR Partners first reported a position in SBBP in Q2 2018 and held it in 2 quarters. The position peaked at $555K in Q2 2018. 49 funds tracked by Wall St. Rank hold SBBP as of Q3 2021.

  • LMR Partners reported no remaining Strongbridge Biopharma plc. position as of Q3 2021 after selling out during the quarter.
  • LMR Partners sold 20,742 Strongbridge Biopharma plc. shares in Q3 2021, an estimated $62K.
  • LMR Partners first reported a position in Strongbridge Biopharma plc. in Q2 2018 and held it in 2 quarters.
  • LMR Partners's Strongbridge Biopharma plc. position peaked at $555K in Q2 2018.
  • 49 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q3 2021.

Based on LMR Partners's 13F filing for Q3 2021, filed 15 Nov 2021.